---
layout: default
title: Table of Contents
nav_order: 0
---

[ Web Links](/ Web Links)
[1. Introduction](/1/1. Introduction)
[2. Overview](/2/2. Overview)
[3. MOP Contents and Organization](/3/3. MOP Contents and Organization)
[3.1 Study Protocol](/3/1/3.1 Study Protocol)
[3.2 Study Organization and Responsibilities](/3/2/3.2 Study Organization and Responsibilities)
[3.2.1 Roster](/3/2/3.2.1 Roster)
[3.2.2 Coordinating Center](/3/2/3.2.2 Coordinating Center)
[3.2.3 Study Sites](/3/2/3.2.3 Study Sites)
[3.2.4 Pharmacy Activities](/3/2/3.2.4 Pharmacy Activities)
[3.2.5 Steering Committees](/3/2/3.2.5 Steering Committees)
[3.2.6 Other Study Committees](/3/2/3.2.6 Other Study Committees)
[3.2.7 NCCIH](/3/2/3.2.7 NCCIH)
[3.3 Training Plan](/3/3/3.3 Training Plan)
[3.4 Communications Plan](/3/4/3.4 Communications Plan)
[3.5 Study Intervention](/3/5/3.5 Study Intervention)
[3.6 Recruitment Plan](/3/6/3.6 Recruitment Plan)
[3.7 Participant Retention](/3/7/3.7 Participant Retention)
[3.8 Study Flow](/3/8/3.8 Study Flow)
[3.9 Screening and Eligibility Criteria](/3/9/3.9 Screening and Eligibility Criteria)
[3.9.1 Screening Log](/3/9/3.9.1 Screening Log)
[3.9.2 Eligibility Criteria](/3/9/3.9.2 Eligibility Criteria)
[3.10 Informed Consent and HIPAA](/3/10/3.10 Informed Consent and HIPAA)
[3.10.1 HIPAA Authorization](/3/10/3.10.1 HIPAA Authorization)
[3.11 Randomization](/3/11/3.11 Randomization)
[3.12 Blinding and Unblinding (Masking and Unmasking)](/3/12/3.12 Blinding and Unblinding (Masking and Unmasking))
[3.13 Study Measurements and Procedures](/3/13/3.13 Study Measurements and Procedures)
[3.13.1 Timeline and Visit Schedule](/3/13/3.13.1 Timeline and Visit Schedule)
[3.13.2 Scope/Schema](/3/13/3.13.2 Scope-Schema)
[3.13.3 Final Study/Early Discontinuation Evaluations](/3/13/3.13.3 Final Study-Early Discontinuation Evaluations)
[3.14 Concomitant Medication](/3/14/3.14 Concomitant Medication)
[3.15 Safety Reporting](/3/15/3.15 Safety Reporting)
[3.16 Study Compliance](/3/16/3.16 Study Compliance)
[3.17 Data Collection and Study Forms](/3/17/3.17 Data Collection and Study Forms)
[3.17.1 Source Documentation](/3/17/3.17.1 Source Documentation)
[3.17.2 Participant Binder](/3/17/3.17.2 Participant Binder)
[3.17.3 Study Forms](/3/17/3.17.3 Study Forms)
[3.17.4 General Instructions for Completing Forms](/3/17/3.17.4 General Instructions for Completing Forms)
[3.18 Data Flow](/3/18/3.18 Data Flow)
[3.19 Administrative Forms](/3/19/3.19 Administrative Forms)
[3.20 Retention of Study Documentation](/3/20/3.20 Retention of Study Documentation)
[3.21 Data Management](/3/21/3.21 Data Management)
[3.21.1 External Data](/3/21/3.21.1 External Data)
[3.22 Quality Control Procedures](/3/22/3.22 Quality Control Procedures)
[3.22.1 Standard Operating Procedures](/3/22/3.22.1 Standard Operating Procedures)
[3.22.2 Data and Form Checks](/3/22/3.22.2 Data and Form Checks)
[3.22.3 Double Data Entry](/3/22/3.22.3 Double Data Entry)
[3.22.4 Site Monitoring](/3/22/3.22.4 Site Monitoring)
[3.23 Reports](/3/23/3.23 Reports)
[3.24 Data and Safety Monitoring Activities](/3/24/3.24 Data and Safety Monitoring Activities)
[3.25 Study Completion and Closeout Procedures](/3/25/3.25 Study Completion and Closeout Procedures)
[3.25.1 Participant Notification](/3/25/3.25.1 Participant Notification)
[3.25.2 Site Procedures](/3/25/3.25.2 Site Procedures)
[3.26 Policies](/3/26/3.26 Policies)
[3.26.1 Confidentiality Procedures](/3/26/3.26.1 Confidentiality Procedures)
[3.26.2 Publications](/3/26/3.26.2 Publications)
[3.27 MOP Maintenance](/3/27/3.27 MOP Maintenance)
[4. References](/4/4. References)
[ Appendix A. Sample Screen Log](/ Appendix A. Sample Screen Log)
[ Appendix B. Sample Schedule of Events](/ Appendix B. Sample Schedule of Events)
[ Appendix C. Sample Protocol Deviation Log](/ Appendix C. Sample Protocol Deviation Log)
[ Appendix D. Sample MOP Modification Log](/ Appendix D. Sample MOP Modification Log)
